Self-sterilising plastic kills viruses such as COVID-19

September 9, 2022
Medical Communications

Scientists from Queen’s University Belfast have developed a virus-killing plastic that could make it harder for bugs, such as COVID-19, …

Brainomix and Bridge Biotherapeutics enter artificial intelligence partnership

September 8, 2022
Business Services

Brainomix – the AI-powered MedTech solutions company – and Bridge Biotherapeutics, a clinical-stage biotechnology company focused on developing novel drugs …

UCB reveals new Bimzelx ‘complete skin clearance’ data

September 8, 2022
Business Services

UCB has announced new three-year results from the BE BRIGHT open-label extension study evaluating the long-term safety, tolerability and efficacy …

BioInnovation Institute reveals new cohort entering Venture Lab programme

September 7, 2022
Research and Development

 The group consists of nine ventures plus two corporate-sponsored innovation projects from Novo Nordisk – all aligned with BII’s focus …

Tomato flu outbreak in India

August 25, 2022
Business Services

An outbreak of a viral infection known as “tomato flu” has led to India’s government issuing an advisory to all …

Number of COVID-19 patients in Scotland’s hospitals drops by 12 percent

August 25, 2022
Business Services

The number of COVID-19 patients in Scotland’s hospitals has fallen by over 12 percent, as shown by the latest weekly …

COVID-19 testing paused in NHS and care homes

August 25, 2022
Business Services

The UK government has shared that most hospital patients and care home residents in England will no longer be tested …

New study reveals the range of co-morbidities faced by patients with type 2 diabetes

August 24, 2022
Research and Development

A new study has revealed the range and type of illnesses that people with type 2 diabetes are living with, …

Oxford Uni scientists study Siga’s Tpoxx for protection against monkeypox

August 24, 2022
Research and Development

The team at Oxford University, who conducted the landmark RECOVERY trial of COVID-19 therapies, is now studying if Siga Technologies’ …

Paediatric Investigation Plan approved by MHRA

August 24, 2022
Research and Development

Northwest Biotherapeutics has announced the approval from the MHRA of the company’s Paediatric Investigation Plan (PIP). The development, regulatory review, …

Togo becomes first country to eliminate four neglected tropical diseases

August 24, 2022
Research and Development

WHO has announced that the Republic of Togo has been confirmed as the first country to eliminate four devastating neglected …

Open Orphan signs £10.4 million contract with global pharma client

August 23, 2022
Manufacturing and Production

Open Orphan has announced that its subsidiary hVIVO has signed a £10.4 million contract with an unnamed major global pharmaceutical …

UK to offer mini dose of monkeypox jab amid low stocks

August 23, 2022
Manufacturing and Production

Three NHS sites will begin a pilot offering eligible patients smaller doses of monkeypox vaccine, following global shortages of the …

Initiative to improve next generation cancer diagnostics

August 23, 2022
Manufacturing and Production

The Medical Device Innovation Consortium (MDIC) has formally launched its Somatic Reference Samples (SRS) Initiative with a pilot project, aiming …

Dengue vaccine approved in Indonesia regardless of prior exposure

August 23, 2022
Manufacturing and Production

Takeda have announced the dengue vaccine, QDENGA®, was approved by the Indonesia National Agency for Drug and Food Control. Dengue …

Approval of only twice-yearly HIV treatment option

August 22, 2022
Sales and Marketing

The European Commission (EC) has granted a Marketing Authorisation for Sunlenca (lenacapavir) injection and tablets for the treatment of HIV …

NICE issues positive appraisal document for combination treatment for advanced kidney cancer

August 22, 2022
Sales and Marketing

NICE has published an appraisal consultation document (ACD) recommending the use of lenvatinib as a therapeutic option for untreated intermediate …

EMA accept marketing authorisation application for invasive candidiasis treatment

August 22, 2022
Sales and Marketing

The EMA has accepted the marketing authorisation application (MAA) for rezafungin, for the treatment of invasive candidiasis in adult patients. …

New WHO recommendations for Ebola treatments and improved access

August 22, 2022
Sales and Marketing

WHO has published its first guideline for Ebola virus disease therapeutics, calling on the global community to increase access to …

mosquito-g4c5e34fdf_1280

GSK awarded UNICEF contract for malaria vaccine

August 19, 2022
Medical Communications

In 2020, nearly half a million children died from malaria in Africa alone, a rate of one child death per …

The Gateway to Local Adoption Series

Latest content